The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pollinosan Hayfever tablets



A.Vogel Ireland LimitedHOA2309/001/001

Main Information

Trade NamePollinosan Hayfever tablets
Active SubstancesAmmi visnagai d1 dilution
Aralia racemose d2 trituration
Cardiospermum halicacabum d2 trituration
Thryallis glauca d3 trituration
Larrea mexicana d2 trituration
Luffa operculata d6 trituration
Okoubaka aubrevillei d2 trituration
Dosage FormTablet
Licence HolderA.Vogel Ireland Limited
Licence NumberHOA2309/001/001

Group Information

ATC Code

Status

License statusAuthorised
Licence Issued31/05/2019
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back